AU2022347098A1 - Idebenone derivatives and their use in treating plants - Google Patents

Idebenone derivatives and their use in treating plants Download PDF

Info

Publication number
AU2022347098A1
AU2022347098A1 AU2022347098A AU2022347098A AU2022347098A1 AU 2022347098 A1 AU2022347098 A1 AU 2022347098A1 AU 2022347098 A AU2022347098 A AU 2022347098A AU 2022347098 A AU2022347098 A AU 2022347098A AU 2022347098 A1 AU2022347098 A1 AU 2022347098A1
Authority
AU
Australia
Prior art keywords
group
groups
compound according
aryl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022347098A
Other languages
English (en)
Inventor
Roberta TORREGROSSA
Matthew Whiteman
Mark Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitorx Therapeutics Ltd
Original Assignee
Mitorx Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitorx Therapeutics Ltd filed Critical Mitorx Therapeutics Ltd
Publication of AU2022347098A1 publication Critical patent/AU2022347098A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/48—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU2022347098A 2021-09-14 2022-09-14 Idebenone derivatives and their use in treating plants Pending AU2022347098A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2113117.2 2021-09-14
GB2113117.2A GB2610815A (en) 2021-09-14 2021-09-14 Compounds
PCT/GB2022/052325 WO2023041906A1 (en) 2021-09-14 2022-09-14 Idebenone derivatives and their use in treating plants

Publications (1)

Publication Number Publication Date
AU2022347098A1 true AU2022347098A1 (en) 2024-04-04

Family

ID=78149340

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022347098A Pending AU2022347098A1 (en) 2021-09-14 2022-09-14 Idebenone derivatives and their use in treating plants

Country Status (10)

Country Link
US (1) US20240400536A1 (https=)
EP (1) EP4396174A1 (https=)
JP (1) JP2024535017A (https=)
KR (1) KR20240108380A (https=)
CN (1) CN118234716A (https=)
AU (1) AU2022347098A1 (https=)
CA (1) CA3231394A1 (https=)
GB (1) GB2610815A (https=)
MX (1) MX2024003214A (https=)
WO (1) WO2023041906A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025104452A1 (en) 2023-11-17 2025-05-22 Mitorx Therapeutics Ltd Compounds for use in treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1664069B8 (en) * 2003-08-22 2015-07-01 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
US8263094B2 (en) 2008-09-23 2012-09-11 Eastman Chemical Company Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof

Also Published As

Publication number Publication date
CN118234716A (zh) 2024-06-21
MX2024003214A (es) 2024-07-30
CA3231394A1 (en) 2023-03-23
KR20240108380A (ko) 2024-07-09
EP4396174A1 (en) 2024-07-10
GB202113117D0 (en) 2021-10-27
WO2023041906A1 (en) 2023-03-23
US20240400536A1 (en) 2024-12-05
GB2610815A (en) 2023-03-22
JP2024535017A (ja) 2024-09-26

Similar Documents

Publication Publication Date Title
AU2001290131B2 (en) Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
EP1441716B1 (en) Alkane diol derivatives as therapeutic agents for the treatment of bone conditions
JP2003535123A (ja) 治療薬としてのバルビツール酸類似体
WO2002026703A1 (en) Carbamic acid compounds comprising an ether linkage as hdac inhibitors
EP3279188B1 (en) Axially chiral isomers, and preparation methods therefor and pharmaceutical uses thereof
WO1999024432A1 (fr) Derives de purine et medicament les renfermant en tant qu'ingredient actif
JP2005511556A6 (ja) 骨疾患の処置のための治療薬としてのアルカンジオール誘導体
WO2007029021A1 (en) 1,5-substituted tetrazoles as therapeutic compounds
EP4074699A1 (en) Compound as cyclin-dependent kinase 9 inhibitor and use thereof
US20100028262A1 (en) 3,4-methylenedioxy-substituted chalcones as therapeutic agents
EP4396174A1 (en) Idebenone derivatives and their use in treating plants
AU2002317303B2 (en) 4-aryl quinols and analogs thereof as therapeutic agents
EP1474397A1 (en) Therapeutic acridone and acridine compounds
KR840002292B1 (ko) 2-[3-[4(3-클로로-4-플루오르페닐)-1-피페라지닐]프로필]-1,2,4-트리아졸로[4,3-a]피리딘-3(2H)-온의 제조방법
WO2010024783A1 (en) Biarylrhodanine and pyridylrhodanine compounds and their use
EP1330456B1 (en) N8,n13 -disubstituted quino[4,3,2-kl]acridinium salts as therapeutic agents
ES2260438T3 (es) Compuestos dinamicos ciclicos que comprenden grupos ciclicos de seis elementos.
WO2025104452A1 (en) Compounds for use in treatment
ES2364312T3 (es) Calconas sustituidas con 4-(alcoxi c2-6) como agentes terapéuticos.
KR20240167916A (ko) 테트라히드로나프탈렌 유도체
JP2008501670A (ja) 骨状態を治療するための治療薬としてのアリールアルキルスルホンアミド類